Leucine-rich alpha-2 glycoprotein is useful in predicting clinical relapse in patients with Crohn’s disease during biological remission

Background/Aims Serum leucine-rich alpha-2 glycoprotein (LRG) is a potential biomarker of Crohn’s disease (CD). This study aimed to evaluate the usefulness of LRG in predicting clinical relapse in patients in remission with CD. Methods This retrospective observational study assessed the relationship...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Naohiro Nakamura, Yusuke Honzawa, Yuka Ito, Yasuki Sano, Naoto Yagi, Sanshiro Kobayashi, Mamiko Aoi, Takashi Tomiyama, Tomomitsu Tahara, Norimasa Fukata, Toshiro Fukui, Makoto Naganuma
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Korean Association for the Study of Intestinal Diseases 2025-04-01
סדרה:	Intestinal Research
נושאים:	crohn disease leucine-rich alpha-2 glycoprotein biomarkers
גישה מקוונת:	http://irjournal.org/upload/pdf/ir-2024-00042.pdf
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!